Stifel Financial’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$227K Buy
+3,496
New +$158K ﹤0.01% 3456
2022
Q2
– Sell
-13,994
Closed -$518K – 3339
2022
Q1
$518K Buy
13,994
+157
+1% +$6.12K ﹤0.01% 2560
2021
Q4
$629K Buy
13,837
+243
+2% +$12.7K ﹤0.01% 2456
2021
Q3
$861K Sell
13,594
-493
-3% -$37.5K ﹤0.01% 2213
2021
Q2
$1.29M Sell
14,087
-70
-0.5% -$5.56K ﹤0.01% 1902
2021
Q1
$964K Sell
14,157
-4,107
-22% -$319K ﹤0.01% 2012
2020
Q4
$1.32M Buy
18,264
+857
+5% +$49.7K ﹤0.01% 1647
2020
Q3
$661K Sell
17,407
-3,504
-17% -$118K ﹤0.01% 1910
2020
Q2
$741K Buy
20,911
+2,043
+11% +$58.1K ﹤0.01% 1751
2020
Q1
$448K Buy
+18,868
New +$423K ﹤0.01% 1937

Other funds holding CDNA

Stifel Financial's CDNA Position: Q3 2026 in Review

Stifel Financial opened a new position in CareDx (CDNA) in Q3 2026: 3,496 shares worth $227K. The stake represents ﹤0.01% of the portfolio and ranks #3456 among its holdings. This is a return to the name: Stifel Financial previously reported a position in CDNA as recently as Q1 2022.

Stifel Financial first reported a position in CDNA in Q1 2020 and has held it in 10 quarters since. The position peaked at $1.32M in Q4 2020. 308 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Stifel Financial held 3,496 shares of CareDx worth $227K as of Q3 2026.
  • CareDx was a new Stifel Financial position in Q3 2026.
  • CareDx made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #3456 holding.
  • Stifel Financial first reported a position in CareDx in Q1 2020 and has held it in 10 quarters since.
  • Stifel Financial's CareDx position peaked at $1.32M in Q4 2020.
  • 308 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.